Global consulting firm calls for revolution in drug marketing.

Ray Moynihan

doi:10.1136/bmj.327.7413.468-d

Global consulting firm calls for revolution in drug marketing.

Ray Moynihan^*

^*Corresponding author for this work

Institute for Evidence-Based Healthcare

Research output: Contribution to journal › Article › Professional

Abstract

A global consulting firm is urging pharmaceutical companies to shift their marketing strategies from targeting individual doctors to influencing senior managers in healthcare systems.

The firm's report Evidence based Healthcare: Overcoming Barriers in Europe has been produced by Frost & Sullivan, a firm providing “growth consulting” and advice to corporate clients in more than 50 countries.

Original language	English
Pages (from-to)	468-468
Number of pages	1
Journal	BMJ (Clinical research ed.)
Volume	327
Issue number	7413
DOIs	https://doi.org/10.1136/bmj.327.7413.468-d
Publication status	Published - 30 Aug 2003

Access to Document

10.1136/bmj.327.7413.468-d

Cite this

@article{ca360a7cfe0248acbe7ad442ea947813,

title = "Global consulting firm calls for revolution in drug marketing.",

abstract = "A global consulting firm is urging pharmaceutical companies to shift their marketing strategies from targeting individual doctors to influencing senior managers in healthcare systems.The firm's report Evidence based Healthcare: Overcoming Barriers in Europe has been produced by Frost & Sullivan, a firm providing “growth consulting” and advice to corporate clients in more than 50 countries.",

author = "Ray Moynihan",

year = "2003",

month = aug,

day = "30",

doi = "10.1136/bmj.327.7413.468-d",

language = "English",

volume = "327",

pages = "468--468",

journal = "BMJ (Clinical research ed.)",

issn = "0959-535X",

publisher = "BMJ Publishing Group",

number = "7413",

}

TY - JOUR

T1 - Global consulting firm calls for revolution in drug marketing.

AU - Moynihan, Ray

PY - 2003/8/30

Y1 - 2003/8/30

N2 - A global consulting firm is urging pharmaceutical companies to shift their marketing strategies from targeting individual doctors to influencing senior managers in healthcare systems.The firm's report Evidence based Healthcare: Overcoming Barriers in Europe has been produced by Frost & Sullivan, a firm providing “growth consulting” and advice to corporate clients in more than 50 countries.

AB - A global consulting firm is urging pharmaceutical companies to shift their marketing strategies from targeting individual doctors to influencing senior managers in healthcare systems.The firm's report Evidence based Healthcare: Overcoming Barriers in Europe has been produced by Frost & Sullivan, a firm providing “growth consulting” and advice to corporate clients in more than 50 countries.

UR - http://www.scopus.com/inward/record.url?scp=0348198284&partnerID=8YFLogxK

U2 - 10.1136/bmj.327.7413.468-d

DO - 10.1136/bmj.327.7413.468-d

M3 - Article

C2 - 12946963

AN - SCOPUS:0348198284

SN - 0959-535X

VL - 327

SP - 468

EP - 468

JO - BMJ (Clinical research ed.)

JF - BMJ (Clinical research ed.)

IS - 7413

ER -

Global consulting firm calls for revolution in drug marketing.

Abstract

Access to Document

Other files and links

Fingerprint

Cite this